Expression and distribution of transcription factor NF-κB and inhibitor IκB in the inflamed peripheral nervous system

Journal of Neuroimmunology

Volumn 116, Issue 2, 2001, Pages 226-232

  Andorfer, Bettina ^a   Kieseier, Bernd C ^a   Mathey, Emily ^b   Armati, Patricia ^b   Pollard, John ^c   Oka, Nobuyuki ^d   Hartung, Hans Peter ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Guillain Barr syndrome; I B; Macrophages; NF B

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; NERVE BIOPSY; NEUROPATHY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHWANN CELL; T LYMPHOCYTE;

GUILLAIN-BARRE SYNDROME; HUMANS; I-KAPPA B PROTEINS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; NF-KAPPA B; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; SURAL NERVE;

EID: 0035364524     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00306-X     Document Type: Article

References (44)

1. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
2. Assessment of current diagnostic criteria for Guillain-Barré syndrome
3. The NF-kappa B and I kappa B proteins: New discoveries and insights
4. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
5. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: A mechanism for cytoplasmic retention
6. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: A mechanism for NF-kappa B activation
7. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy
8. Role of nuclear factor-kappa B in atherogenesis
9. Quantitative analysis of endoneurial T cells in human sural nerve biopsies
10. The effect of suppression of macrophage activity on the development of experimental allergic neuritis
11. The activation of nuclear factor kappa B in brains from children with HIV-1 encephalitis
12. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
13. Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro
14. T-cell apoptosis in autoimmune diseases: Termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms
15. Macrophage system in peripheral nerves. A review
16. Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions
17. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65
18. T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome
19. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations
20. Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase
21. Invited review - Immunopathogenesis and treatment of Guillain-Barré Syndrome, Part I and II
22. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
23. Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression
24. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies
25. The role of macrophages in immunemediated damage to the peripheral nervous system
26. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barre syndrome
27. Sequential expression of chemokines in experimental autoimmune neuritis
28. Upregulation of matrix metalloproteinase-9 in the cerebrospinal fluid of patiens with acute Lyme neuroborreliosis
29. NF-kappa B and rel proteins in innate immunity
30. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells
31. NF-kappa B as a therapeutic target in chronic inflammation: Recent advances
32. The neurobiology of Schwann cells
33. T cell subsets and Ia-positive cells in the sciatic nerve during the course of experimental allergic neuritis
34. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression
35. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy
36. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system
37. NF-κB: A key role in inflammatory diseases
38. Protection against experimental autoimmune neuritis with silicia quartz dust
39. Eighty three years of the Guillain-Barré syndrome: Clinical and immunopathologic aspects, current and future treatments
40. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
41. Immunohistochemical analysis of the activation of NF-kappaB and expression of associated cytokines and adhesion molecules in human models of allergic inflammation
42. Regulation of Fas and FasL expression on rat Schwann cells
43. Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat